Oregon Revised Statute Chapter 433 Mandatory Reporting of Communicable Diseases Flashcards
- 004 Reportable diseases; duty to report; investigation; effect of failure to report; rules
(1) The Oregon Health Authority shall by rule: (a) Specify reportable diseases;
(1) The Oregon Health Authority shall by rule:
(a) Specify reportable diseases;
(b) Identify those categories of persons who must report reportable diseases and the circumstances under which the reports must be made;
(c) Prescribe the procedures and forms for making such reports and transmitting the reports to the authority; and
(d) Prescribe measures and methods for investigating the source and controlling reportable diseases.
- 004 Reportable diseases; duty to report; investigation; effect of failure to report; rules
(2) Persons required under the rules to report
(2) Persons required under the rules to report reportable diseases shall do so by reporting to the local public health administrator. The local public health administrator shall transmit such reports to the authority.
- 004 Reportable diseases; duty to report; investigation; effect of failure to report; rules
(3) The authority or local public health administrator may investigate a case of a reportable disease, disease outbreak or epidemic.
The investigation may include, but is not limited to:
(3) The authority or local public health administrator may investigate a case of a reportable disease, disease outbreak or epidemic. The investigation may include, but is not limited to:
(a) Interviews of: (A) The subject of a reportable disease report; (B) Controls; (C) Health care providers; or (D) Employees of a health care facility.
(b) Requiring a health care provider, any public or private entity, or an individual who has information necessary for the investigation to:
(A) Permit inspection of the information by the authority or local public health administrator; and
(B) Release the information to the authority or local public health administrator.
(c) Inspection, sampling and testing of real or personal property with consent of the owner or
custodian of the property or with an administrative warrant.
- 004 Reportable diseases; duty to report; investigation; effect of failure to report; rules
(4) (a) The authority shall establish by rule the manner in which information may be requested and obtained under subsection (3) of this section.
(4)(a) The authority shall establish by rule the manner in which information may be requested and obtained under subsection (3) of this section. (b) Information requested may include, but is not limited to, individually identifiable health information related to:
(A) The case;
(B) An individual who may be the potential source of exposure or infection;
(C) An individual who has been or may have been exposed to or affected by the disease;
(D) Policies, practices, systems or structures that may have affected the likelihood of disease transmission; and
(E) Factors that may influence an individual’s susceptibility to the disease or likelihood of being diagnosed with the disease.
- 004 Reportable diseases; duty to report; investigation; effect of failure to report; rules
(5) In addition to other grounds for which a state agency may exercise disciplinary action against its licensees or certificate holders
(5) In addition to other grounds for which a state agency may exercise disciplinary action against its licensees or certificate holders, the substantial or repeated failure of a licensee or certificate holder to report when required to do so under subsection (2) or (3) of this section shall be cause for the exercise of any of the agency’s disciplinary powers.
- 004 Reportable diseases; duty to report; investigation; effect of failure to report; rules
(6) Any person making a report or providing information under this section is immune from any civil or criminal liability
(6) Any person making a report or providing information under this section is immune from any civil or criminal liability that might otherwise be incurred or imposed with respect to the making of a report or providing information under this section.
333-018-0000
Who is Responsible for Reporting: (1-4)
(1) Each health care provider knowing of or attending a human case or suspected human case of any of the diseases, infections, or conditions listed in OAR 333-018-0015 shall report such cases as specified. Where no health care provider is in attendance, any individual knowing of such a case shall report in a similar manner. An individual required to report reportable diseases who is unsure whether a case meets the definition of a suspect case as that is defined in OAR 333- 017-0000 should err on the side of reporting if the suspected disease, infection, or condition is one that:
(a) Is required to be reported immediately or within 24 hours under OAR 333-018-0015;
(b) Is highly transmissible; or
(c) Results in serious or severe health consequences.
(2) Each health care facility, where more than one health care provider may know or attend a human case or suspected human case, may establish administrative procedures to ensure that every case is reported.
(3) Each licensed laboratory shall report human test results as specified in OAR 333-018-0015(5). When more than one licensed laboratory is involved in testing a specimen, the laboratory that is responsible for reporting the test result directly to the health care provider that ordered the test shall be responsible for reporting.
(4) Each veterinary laboratory or licensed laboratory shall report animal test results as specified in OAR 333-018-0017. When more than one laboratory is involved in testing a specimen, the laboratory that is responsible for reporting the test result directly to the licensed veterinarian or client of record caring for the
animal shall be responsible for reporting.
333-018-0005
To Whom Reports Shall Be Made (1-4)
(1) In general, if the patient is an Oregon resident, reports shall be made to the local public health administrator for the patient’s place of residence.
(2) In lieu of reporting to the local public health administrator, with the consent of the local public health administrator and the Authority, reports may be made directly to the Authority (for example, via electronic reporting).
(3) In urgent situations when local public health staff are unavailable, case reports shall be made directly to the Authority.
(4) Where the case is not an Oregon resident, reports shall be made either to the patient’s local public health authority (if the patient resides in the United States) or directly to the Authority.
(5) In lieu of reporting to the local public health administrator, with the consent of the local public health administrator, licensed laboratories shall report directly to the Authority’s HIV Program: (a) All tests indicative of and specific for HIV infection as required by OAR 333-018-0015;
(b) All CD4+ T-lymphocyte counts; and
(c) All HIV viral load tests.
333-018-0010
Form of the Report (1-4)
(1) A health care provider required to report reportable diseases under ORS 433.004 and these rules shall submit to the local public health administrator a report that includes but is not limited to:
(a) The identity, address, and telephone number of the person reporting;
(b) The identity, address, and telephone number of the attending health care provider, or other treating health care provider if any;
(c) The name of the person affected or ill, that person’s current address, telephone number, and date of birth;
(d) The diagnosed or suspected disease, infection, or condition; and
(e) The date of illness onset.
(2) A licensed laboratory required to report reportable diseases under ORS 433.004 and these rules shall submit to the local public health administrator a report that includes but is not limited to:
(a) The name and telephone number of the reporting laboratory;
(b) The name, gender, age or date of birth, the address and county of residence of the person from whom the laboratory specimen was obtained, if known;
(c) The date the specimen was obtained;
(d) The name, address and telephone number of the health care provider of the person from whom the laboratory specimen was obtained;
(e) The name or description of the test;
(f) The test result; and
(g) Information required by the Authority’s Manual for Mandatory Electronic Laboratory Reporting, if electronic reporting is required under OAR 333-018-0013.
(3) Reportable disease reports shall be made in the following manner:
(a) Reports for diseases or suspected diseases that are immediately reportable under OAR 333-018- 0015 shall be submitted orally, by telephone, with a follow-up written report via facsimile.
(b) Reports for diseases or suspected diseases that are required to be reported within one to seven days under OAR 333-018-0013 shall be submitted in writing via facsimile or by other means approved by the local public health administrator, consistent with the need for timely reporting as provided in OAR 333-018-0015.
(c) Electronically, if required by OAR 333-018- 0013.
(4) If requested by a local public health administrator or the Oregon Public Health Division, health care providers and licensed laboratories shall provide additional information of relevance to the investigation or control of reportable diseases or conditions (for example, reported signs and symptoms, laboratory test results (including negative results), potential
exposures, contacts, and clinical outcomes).
333-018-0015
What Is to Be Reported and When (1-5)
(1) Health care providers shall report all human cases or suspected human cases of the diseases, infections, microorganisms, and conditions specified below. The timing of health care provider reports is specified to reflect the severity of the illness or condition and the potential value of rapid intervention by public health agencies.
(2) When local public health administrators cannot be reached within the specified time limits, reports shall be made directly to the Authority, which shall maintain an around-the- clock public health consultation service.
(3) Licensed laboratories shall report all test results indicative of and specific for the diseases, infections, microorganisms, and conditions specified below for humans. Such tests include but are not limited to: microbiological culture, isolation, or identification; assays for specific antibodies; and identification of specific antigens, toxins, or nucleic acid sequences.
(4) Human reportable diseases, infections, microorganisms, and conditions, and the time frames within which they must be reported are as follows:
(a) Immediately, day or night: Bacillus anthracis (anthrax); Clostridium botulinum (botulism); Corynebacterium diphtheriae (diphtheria); novel influenza; Yersinia pestis (plague); poliomyelitis; rabies (human); measles (rubeola); Severe Acute Respiratory Syndrome (SARS) and infection by SARS coronavirus; rubella; variola major (smallpox); Francisella tularensis (tularemia); Vibrio cholerae O1, O139, or toxigenic; hemorrhagic fever caused by viruses of the filovirus (e.g., Ebola, Marburg) or arenavirus (e.g., Lassa, Machupo) families; yellow fever; intoxication caused by marine microorganisms or their byproducts (for example, paralytic shellfish poisoning, domoic acid intoxication, ciguatera, scombroid); any known or suspected common- source outbreaks; any uncommon illness of potential public health significance.
(b) Within 24 hours (including weekends and holidays): Haemophilus influenzae (any invasive disease; for laboratories, any isolation or identification from a normally sterile site); Neisseria meningitidis (any invasive disease; for laboratories, any isolation or identification from a normally sterile site); pesticide poisoning.
(c) Within one local public health authority working day: Bordetella pertussis (pertussis); Borrelia (relapsing fever, Lyme disease); Brucella (brucellosis); Campylobacter (campylobacteriosis); Chlamydophila (Chlamydia) psittaci (psittacosis); Chlamydia trachomatis (chlamydiosis; lymphogranuloma venereum); Clostridium tetani (tetanus); Coxiella burnetii (Q fever); Creutzfeldt-Jakob disease and other transmissible spongiform encephalopathies; Cryptococcus (cryptococcosis), Cryptosporidium (cryptosporidiosis); Cyclospora cayetanensis (cyclosporosis); bacteria of the Enterobacteriaceae family found to be non- susceptible to third-generation cephalosporins and to carbapenem antibiotic (other than ertapenem); Escherichia coli (Shiga-toxigenic, including E. coli O157 and other serogroups); Giardia (giardiasis); Grimontia spp.; Haemophilus ducreyi (chancroid); hantavirus; hepatitis A; hepatitis B (acute or chronic infection); hepatitis C; hepatitis D (delta); hepatitis E; HIV infection (does not apply to anonymous testing) and AIDS; death of a person <18 years of age with laboratory-confirmed influenza; lead poisoning; Legionella (legionellosis); Leptospira (leptospirosis); Listeria monocytogenes (listeriosis); mumps; Mycobacterium tuberculosis and M. bovis (tuberculosis); nonrespiratory infection with nontuberculous mycobacteria; Neisseria gonorrhoeae (gonococcal infections); pelvic inflammatory disease (acute, non-gonococcal); Plasmodium (malaria); Rickettsia (all species: Rocky Mountain spotted fever, typhus, others); Salmonella (salmonellosis, including typhoid); Shigella (shigellosis); Taenia solium (including cysticercosis and undifferentiated Taenia infections); Treponema pallidum (syphilis); Trichinella (trichinosis); Vibrio spp.; Yersinia (other than pestis); any infection that is typically arthropod vector-borne (for example: babesiosis, California encephalitis, Colorado tick fever, dengue, Eastern equine encephalitis, ehrlichiosis, Heartland virus infection, Kyasanur Forest disease, St. Louis encephalitis, West Nile fever, Western equine encephalitis, etc.); a human bitten by any other mammal; and hemolytic uremic syndrome.
(d) Within seven days: Any blood lead level tests including the result.
(5) Licensed laboratories shall report, within seven days, the results of all tests of CD4+ T- lymphocyte absolute counts and the percent of
total lymphocytes that are CD4 positive, and HIV
nucleic acid (viral load) tests.
333-018-0018
Submission of Isolates to the Public Health Laboratory (1-7)
Licensed laboratories are required to forward aliquots or subcultures of the following to the Oregon State Public Health Laboratory:
(1) Suspected Neisseria meningitidis and Haemophilus influenzae from normally sterile sites.
(2) Suspected Shiga-toxigenic Escherichia coli (STEC), including E. coli O157; Salmonella spp., Shigella spp., Vibrio spp., Grimontia spp., Listeria spp., Yersinia spp.; Mycobacterium tuberculosis and M. bovis from any source.
(3) Serum that tests positive for IgM antibody to hepatitis A virus.
(4) Serum that tests positive for IgM core antibody to hepatitis B virus.
(5) All cryptococcal isolates.
(6) All isolates of the Enterobacteriaceae family resistant to third-generation cephalosporins and non-susceptible to any carbapenem antibiotic other than ertapenem.
(7) For persons under the age of 18 who died with laboratory-confirmed influenza: respiratory specimens or viral isolates, any Staphylococcus aureus isolates, and, after consulting with the Oregon Public Health Division, autopsy
specimens.
333-018-0020
Reports from Local Public Health Administrators (1-3)
(1) The local public health administrator shall notify the Authority immediately of any reported cases of the following diseases and conditions: anthrax, botulism (foodborne), cholera, diphtheria, marine intoxications, measles, pesticide poisoning, plague, poliomyelitis, rabies; any uncommon illness of potential public health significance; any outbreak of disease.
(2) Animal bites that have been investigated by the local public health administrator and for which testing of the biting animal for rabies has been deemed unnecessary need not be reported to the Authority.
(3) For other reportable diseases and conditions, the local public health administrator shall notify the Authority no later than the end of each business week of all cases reported during that week. Reports shall be made by means approved by the Authority and in a format approved by the
Authority.
333-018-0035
Procedures Involving Emergency Response Employees (1-6)
(1) Each person or local government employing persons to render emergency care shall designate a contact person or “designated officer” to receive reports from the local public health administrator made under ORS 433.006. The employer shall assure that the designated officer has sufficient training to carry out the duties as described below, which shall include appropriate procedures for follow-up after occupational exposures to specific diseases as specified below in section (2) and section (6).
(2) Sections (3) through (5) apply only to the following subset of reportable diseases: meningococcal disease, infectious pulmonary or laryngeal tuberculosis, diphtheria, plague (Yersinia pestis), rabies, hemorrhagic fevers (for example, Lassa, Marburg, and Ebola).
(3) Health care providers and health care facilities shall, when reporting this subset of diseases, determine and include as part of their report whether or not an emergency care provider was involved in pre-hospital care for this disease.
(4) Health care providers and facilities shall report to the local public health administrator and may relay the diagnosis of these diseases directly to the emergency care providers or the designated officer specified below in section (5), but shall not disclose the identity or addresses of the person having the disease or otherwise refer specifically to the person.
(5) Upon receiving a report of a reportable disease as defined in section (2) above, the designated officer shall notify all out-of-hospital caregivers, including but not limited to: first responders, emergency medical technicians, paramedics, firefighters, law enforcement officers, corrections officers, probation officers, or other current or former personnel of the employer who may have been exposed to the reportable disease. The designated officer shall inform the personnel only of the reportable disease and the fact of possible exposure and the appropriate follow-up procedures. The designated officer shall not inform the personnel of the identity or addresses of the individual having the reportable disease or otherwise refer specifically to the individual having the reportable disease.
(6) In the event of an occupational exposure to a bloodborne pathogen as defined by ORS 433.060, the designated officer shall also assist the exposed worker as defined in ORS 433.060 in implementing the provisions of ORS 433.065 through ORS 433.080 and associated Authority rules (chapter 333, division 22). These rules include provisions for determining HIV, hepatitis B and hepatitis C status of the source patient and soliciting HIV testing after an occupational
exposure.
